Cargando…

An Endocrinological Perspective on 22q11.2 Deletion Syndrome: A Single-center Experience

OBJECTIVE: 22q11.2 deletion syndrome (22q11.2 DS) is the most common chromosomal microdeletion disorder. Associated problems in 22q11.2 DS may include cardiac abnormalities, immune dysfunction, facial dysmorphism, with endocrine, genitourinary and gastrointestinal problems, and developmental delay....

Descripción completa

Detalles Bibliográficos
Autores principales: Denkboy Öngen, Yasemin, Özemri Sağ, Şebnem, Temel, Şehime Gülsün, Eren, Erdal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Galenos Publishing 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10448559/
https://www.ncbi.nlm.nih.gov/pubmed/37074225
http://dx.doi.org/10.4274/jcrpe.galenos.2023.2022-11-3
_version_ 1785094762179592192
author Denkboy Öngen, Yasemin
Özemri Sağ, Şebnem
Temel, Şehime Gülsün
Eren, Erdal
author_facet Denkboy Öngen, Yasemin
Özemri Sağ, Şebnem
Temel, Şehime Gülsün
Eren, Erdal
author_sort Denkboy Öngen, Yasemin
collection PubMed
description OBJECTIVE: 22q11.2 deletion syndrome (22q11.2 DS) is the most common chromosomal microdeletion disorder. Associated problems in 22q11.2 DS may include cardiac abnormalities, immune dysfunction, facial dysmorphism, with endocrine, genitourinary and gastrointestinal problems, and developmental delay. The aim of this study was to evaluate and present all endocrinological findings of patients with 22q11.2 DS from a single center. METHODS: All participants had confirmed 22q11.2 DS by fluorescence in situ hybridization with hypoparathyroidism. Data were retrieved by retrospective review of patient records. RESULTS: A total of 17 patients were reviewed. On physical examination, all patients had similar dysmorphic features. The median age at diagnosis was 45 days (1 day-13 years). Most cases (64.7%, 11/17) were diagnosed with hypoparathyroidism incidentally after routine tests. At the time of diagnosis, mean calcium was 7.04±0.80 mg/dL, phosphorus was 6.2±1.1 mg/dL, and median parathyroid hormone (PTH) was 11.5 (3.7-47.6) ng/L. Transient hypoparathyroidism was detected in five cases (29.4%). There was no significant difference between patients with permanent or transient hypoparathyroidism regarding gender, age at diagnosis, calcium, phosphorus, and PTH levels. However, vitamin D levels were significantly lower in the transient group (p=0.036). During follow-up, short stature, obesity, and type 2 diabetes mellitus were absent. Thyroid autoantibodies were detected in two patients with normal thyroid function tests. Despite there being no pathological short stature, final stature was shorter than the general population (mean height standard deviation score: -0.94±0.83). CONCLUSION: Hypocalcemia may be detected during acute illness in some cases where hypocalcemia appears at later ages. There was no significant difference between permanent and transient hypoparathyroidism cases in terms of PTH level. Recognition of the more specific facial findings is important to trigger investigation of genetic variants, additional anomalies, and for follow-up.
format Online
Article
Text
id pubmed-10448559
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Galenos Publishing
record_format MEDLINE/PubMed
spelling pubmed-104485592023-09-01 An Endocrinological Perspective on 22q11.2 Deletion Syndrome: A Single-center Experience Denkboy Öngen, Yasemin Özemri Sağ, Şebnem Temel, Şehime Gülsün Eren, Erdal J Clin Res Pediatr Endocrinol Original Article OBJECTIVE: 22q11.2 deletion syndrome (22q11.2 DS) is the most common chromosomal microdeletion disorder. Associated problems in 22q11.2 DS may include cardiac abnormalities, immune dysfunction, facial dysmorphism, with endocrine, genitourinary and gastrointestinal problems, and developmental delay. The aim of this study was to evaluate and present all endocrinological findings of patients with 22q11.2 DS from a single center. METHODS: All participants had confirmed 22q11.2 DS by fluorescence in situ hybridization with hypoparathyroidism. Data were retrieved by retrospective review of patient records. RESULTS: A total of 17 patients were reviewed. On physical examination, all patients had similar dysmorphic features. The median age at diagnosis was 45 days (1 day-13 years). Most cases (64.7%, 11/17) were diagnosed with hypoparathyroidism incidentally after routine tests. At the time of diagnosis, mean calcium was 7.04±0.80 mg/dL, phosphorus was 6.2±1.1 mg/dL, and median parathyroid hormone (PTH) was 11.5 (3.7-47.6) ng/L. Transient hypoparathyroidism was detected in five cases (29.4%). There was no significant difference between patients with permanent or transient hypoparathyroidism regarding gender, age at diagnosis, calcium, phosphorus, and PTH levels. However, vitamin D levels were significantly lower in the transient group (p=0.036). During follow-up, short stature, obesity, and type 2 diabetes mellitus were absent. Thyroid autoantibodies were detected in two patients with normal thyroid function tests. Despite there being no pathological short stature, final stature was shorter than the general population (mean height standard deviation score: -0.94±0.83). CONCLUSION: Hypocalcemia may be detected during acute illness in some cases where hypocalcemia appears at later ages. There was no significant difference between permanent and transient hypoparathyroidism cases in terms of PTH level. Recognition of the more specific facial findings is important to trigger investigation of genetic variants, additional anomalies, and for follow-up. Galenos Publishing 2023-09 2023-08-23 /pmc/articles/PMC10448559/ /pubmed/37074225 http://dx.doi.org/10.4274/jcrpe.galenos.2023.2022-11-3 Text en ©Copyright 2023 by Turkish Pediatric Endocrinology and Diabetes Society | The Journal of Clinical Research in Pediatric Endocrinology published by Galenos Publishing House. https://creativecommons.org/licenses/by-nc-nd/4.0/Licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 (CC BY-NC-ND) International License.
spellingShingle Original Article
Denkboy Öngen, Yasemin
Özemri Sağ, Şebnem
Temel, Şehime Gülsün
Eren, Erdal
An Endocrinological Perspective on 22q11.2 Deletion Syndrome: A Single-center Experience
title An Endocrinological Perspective on 22q11.2 Deletion Syndrome: A Single-center Experience
title_full An Endocrinological Perspective on 22q11.2 Deletion Syndrome: A Single-center Experience
title_fullStr An Endocrinological Perspective on 22q11.2 Deletion Syndrome: A Single-center Experience
title_full_unstemmed An Endocrinological Perspective on 22q11.2 Deletion Syndrome: A Single-center Experience
title_short An Endocrinological Perspective on 22q11.2 Deletion Syndrome: A Single-center Experience
title_sort endocrinological perspective on 22q11.2 deletion syndrome: a single-center experience
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10448559/
https://www.ncbi.nlm.nih.gov/pubmed/37074225
http://dx.doi.org/10.4274/jcrpe.galenos.2023.2022-11-3
work_keys_str_mv AT denkboyongenyasemin anendocrinologicalperspectiveon22q112deletionsyndromeasinglecenterexperience
AT ozemrisagsebnem anendocrinologicalperspectiveon22q112deletionsyndromeasinglecenterexperience
AT temelsehimegulsun anendocrinologicalperspectiveon22q112deletionsyndromeasinglecenterexperience
AT erenerdal anendocrinologicalperspectiveon22q112deletionsyndromeasinglecenterexperience
AT denkboyongenyasemin endocrinologicalperspectiveon22q112deletionsyndromeasinglecenterexperience
AT ozemrisagsebnem endocrinologicalperspectiveon22q112deletionsyndromeasinglecenterexperience
AT temelsehimegulsun endocrinologicalperspectiveon22q112deletionsyndromeasinglecenterexperience
AT erenerdal endocrinologicalperspectiveon22q112deletionsyndromeasinglecenterexperience